Literature DB >> 27377756

Percutaneous alcohol septal ablation to acutely reduce left ventricular outflow tract obstruction induced by transcatheter mitral valve replacement.

Mayra Guerrero1, Dee Dee Wang2, William O'Neill2.   

Abstract

Transcatheter implantation of balloon expandable valves in native mitral valves (MV) has been performed in patients with severe MV annular calcification who are not good candidates for standard surgical MV replacement. Significant left ventricular outflow tract (LVOT) obstruction with hemodynamic compromise has been described as one of the potential complications of transcatheter MV replacement. Surgical rescue carries significant risk in this high-risk patient population. We describe a percutaneous technique to acutely decrease transcatheter MV replacement-induced LVOT obstruction.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  mitral valve disease; percutaneous intervention; percutaneous valve therapy; septal ablation; transcatheter valve implantation

Mesh:

Substances:

Year:  2016        PMID: 27377756     DOI: 10.1002/ccd.26649

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

Review 1.  Transseptal Transcatheter Mitral Valve Replacement for Post-Surgical Mitral Failures.

Authors:  Marvin H Eng; Dee Dee Wang
Journal:  Interv Cardiol       Date:  2018-05

2.  Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience.

Authors:  Vasilis C Babaliaros; Adam B Greenbaum; Jaffar M Khan; Toby Rogers; Dee Dee Wang; Marvin H Eng; William W O'Neill; Gaetano Paone; Vinod H Thourani; Stamatios Lerakis; Dennis W Kim; Marcus Y Chen; Robert J Lederman
Journal:  JACC Cardiovasc Interv       Date:  2017-04-24       Impact factor: 11.195

3.  Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.

Authors:  Jaffar M Khan; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2018-08-01       Impact factor: 2.692

4.  Anterior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement.

Authors:  Jaffar M Khan; Vasilis C Babaliaros; Adam B Greenbaum; Jason R Foerst; Shahram Yazdani; James M McCabe; Gaetano Paone; Marvin H Eng; Bradley G Leshnower; Patrick T Gleason; Marcus Y Chen; Dee Dee Wang; Xin Tian; Annette M Stine; Toby Rogers; Robert J Lederman
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

5.  Transcatheter Mitral Valve Replacement for Treating Native Mitral Valve Disease: Current Status.

Authors:  Yan Chen; Junjie Hu; Shunqiang Wu; San Zhang; Kaiqin Wu; Wenli Wang; Yongxin Zhou
Journal:  Tex Heart Inst J       Date:  2020-08-01

Review 6.  Current Status of Catheter-based Mitral Valve Replacement.

Authors:  Elias Rawish; Tobias Schmidt; Ingo Eitel; Christian Frerker
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

7.  Transseptal, Transcatheter Mitral Valve-In-Valve Replacement: Ready for Prime Time Treatment of Bioprosthetic Valve Failure in Brazil?

Authors:  Dimytri Alexandre Alvim de Siqueira; Auristela Isabel de Oliveira Ramos; Fausto Feres
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.